$81million NIH grant to study nursing home dementia care … Consider these documentation practices help mitigate litigation risks for providers … Senator urges CMS to crack down on Medicaid MCOs denying...
Burden of persistent symptoms high after COVID-19 infection
May 24, 2022
– A high burden of persistent symptoms is observed in persons after COVID-19, but no specific causes of symptoms of postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)...
U.S. to test vaccine combos for future anti-variant strategy, Fauci says
Apr 01, 2022
The NIH is launching a phase 2 clinical trial to help determine which vaccine combos can provide a broader immune response in adults who have already had a series of COVID-19 vaccinations.
More U.S. adults using melatonin as sleep aid despite lack of evidence
Mar 04, 2022
Use of the supplement melatonin by U.S. adults has more than quintupled between 1999 and 2018, a new study has found.
NIH panel updates treatment guidelines for non-hospitalized COVID-19 patients
Jan 25, 2022
A new recommended treatments list addresses the omicron variant’s current dominance and drug supply shortages.
NIH spending nearly $470 million on ‘long-haul COVID’ study
Sep 16, 2021
Goal is to uncover why some people have prolonged symptoms or develop new or returning symptoms after recovering from COVID-19
NIH head says full Pfizer vaccine approval could come this summer
Jul 20, 2021
Waiting for full federal approval of Pfizer’s COVID-19 vaccine is no reason to delay protection, the director of the National Institutes of Health said Monday, but those still holding out for the end...
Antigen tests just as effective as PCR in preventing COVID outbreaks, NIH study finds
Jul 02, 2021
A “highly anticipated” study now shows that both testing approaches can give 98% sensitivity when used at least twice weekly in a screening program.
Robust response to virus variants expected in former COVID patients and the vaccinated
Mar 31, 2021
Blood samples from recovered COVID-19 patients show that they and their vaccinated peers should be able to fend off the virus and its variants in future encounters, NIH researchers say.
Fauci: ‘Pan-viral’ vaccine may be needed to tackle tenacious COVID-19 long-term
Feb 16, 2021
The virus that causes COVID-19 likely is here to stay, and its success in humans means that stronger defense measures will be needed, say Anthony Fauci, M.D., and colleagues from the National Institute...